Aim: It has been reported that bone marrow-derived cells (BMDC) can be original cells of mouse gastric cancers induced by Helicobacter felis (H. felis) infection. However, it is unknown whether BMDCs are also the original cells of mouse gastrointestinal cancers induced by gastric carcinogens N-nitroso-N-methylurea (NMU) and H. felis infection.
Introduction
Bone marrow-derived cells (BMDCs) possess a wide range of plasticity and tend to migrate through peripheral organs as a result of inflammation and tissue injury [1, 2] . The differentiation pattern and growth regulation of these cells depend largely on local environmental signals and cues [3] . Chronic gastric inflammation, which develops as a consequence of Helicobacter pylori (H. Pylori) infection, leads to repetitive injury and repair resulting in the development of gastric adenocarcinoma in human [4, 5] . Studies in mice infected with the related mouse-adapted Helicobacter species, H. felis, have suggested that adult mouse BMDCs are capable of initiating gastric cancer or contributing to the tumor microenvironment [6, 7] .
Although H. pylori infection is classified as the first class of carcinogen for human gastric mucosa-associated lymphoid tissue lymphoma (MALT lymphoma) and main cause of chronic gastritis and digestive ulceration, it is not certain whether H. pylori infection directly induces human gastric adenocarcinomas. N-Nitroso compounds are strong gastric carcinogen for many animals. NNitroso compounds, deficiency of dietary protein and vitamin C, and high salt intake, as well as H. pylori infection, are all risk factors of stomach cancers. N-Nitroso-N-methylurea (NMU), which can be synthesized in the human and animal stomach [8, 9] , is a highly reliable animal gastric chemical carcinogen. Various cancers have been induced by NMU in animal models including rodent gastric carcinoma [10, 11] . In this paper, we investigated whether BMDCs can trans-differentiate into cancer cells in the NMU/H. felis induced mouse gastrointestinal cancers.
Materials and Methods

Animals
C57BL/6-Tg b-actin-enhanced green fluorescence protein (CAG-EGFP) transgenic mice were purchased from Cyagen Biosciences Inc (Guangzhou). Six weeks old wild type C57BL/6 mice were purchased from Acad. Military Med. Sci. (Beijing) and observed one week before experiments. All mice studies were carried out in a germ-free environment under the approval of Administration Committee on Experiment Animals, Peking University Cancer Hospital and Institute. The body weight of each mouse was recorded every week ( Figure 1 ).
Bone marrow cell (BMC) isolation
BMCs were flushed from the femurs and tibias of 6-8 weeks old C57BL/6-Tg (CAG-EGFP) transgenic mice. BMCs from the donor mice were pooled together and filtered through a 40 mm cell strainer to produce a single cell suspension in PBS.
Bone marrow transplantation (BMT)
Seven weeks old recipient C57BL/6 mice (body weight 18-20 g) were irradiated with 10 Gy X-ray, reconstituted with 3610 6 donor BMCs via a single tail vein injection, and used for experiments after 4 weeks of recovery as described [6] . All recipient mice drank gentamycin-containing water (0.32 g/L) for 14 days immediately following the radiation.
Administration of carcinogen
The experimental mouse model of gastrointestinal carcinogenesis was setup as described [11] . N-Nitroso-N-methylurea (NMU, N1517, Sigma, St. Louis, MO) was freshly dissolved in distilled drinking water (concentration, 240 ppm) in light-shielded bottles. Sixty nime BMT mice were divided into 2 groups, 54 mice drank the NMU-containing water on alternate weeks for a total five weeks from the 5 th to the 14 th experimental week after the BMT. The other 15 mice drank regular drinking water without NMU as negative control.
H. felis (ATCC 49179, Rockville, MD) was grown for 48 hours at 37uC under microaerobic conditions on 5% sheep blood agar. 45 NMU-treated mice and 5 drinking-water mice were subsequently infected by intragastric gavage with 1610 8 colony forming units (CFU) every other day for 3 days (1 time per day) in the 13th experimental week. The remaining 19 mice were gavaged with the broth control.
Histopathologic examination
Mice were euthanized by CO 2 inhalation in the 80th experimental week. Their stomachs were opened along the greater curvature. Linear longitudinal sections from the squamocolumnar junction through the pylorus as well as the small intestines were collected. Tissue samples with optically visible neoplasia were frozen with liquid nitrogen and used in direct-fluorescence assay as described below. Most tissue samples from the stomach and intestine were fixed with 10% formalin, embedded in paraffin, cut into 5 mm sections, and stained with hematoxylin-eosin (H&E). Histologic diagnosis was made using the criteria proposed by Leininger and Jokinen [12] .
Immunohistochemistry staining (IHC)
Slides were incubated with primary antibody against GFP (1:2000; AB290, Abcam, Cambridge, MA) at 4uC overnight. Biotinylated secondary antibody (Zymed, San Francisco, CA) and avidin-biotin DAB detection kit (Zhongshan Jinqiao, Beijing) were used for detection and visualization of GFP(+) cells according to the protocol.
Direct fluorescence and indirect immuno-fluorescence staining
For GFP direct fluorescence tracing, frozen sections (5 mm) were washed in PBS, counterstained with 1 mg/mL DAPI (Sigma), and viewed with a Leica confocal microscope. After the fluorescence observation, these slides were further H&E-stained.
For dual fluorescence immuno-staining, slides were incubated with primary antibody against CD45 (1:100; B0848, Anbobio, San Francisco, CA), a-smooth muscle actin (aSMA) (1:250; AB7817, Abcam) or serum response factor (SRF) (1:75; AB53147, Abcam) at 4uC overnight, then with TRITC-conjugated secondary antibody (Abcam) for 1 hour at room temperature and observed as described above.
Flowcytometry analysis
For GFP(+) cell analysis, bone marrow cell suspension was prepared in PBS as described above. Red blood cells were 
Results
Effects of X-ray Irradiation-BMT and Carcinogen Treatments on Mice
To label the BMDCs with GFP, wild type C57BL/6 mice were irradiated with a lethal dose of X-ray (10 Gy) and transplanted with 3610 6 bone marrow cells derived from C57BL/6-Tg (CAG-EGFP) transgenic mice. Donor cells engraftment was approximately 60% to 90% as assessed by flowcytometry and confocal analysis of GFP(+) cells in the bone marrow suspension and peripheral leukocytes from these recipient mice after 4 weeks' recovery ( Figure S1 and S2). These results were similar to the reported engraftment level (60,80%) [6] . Four control mice without BMT died within two weeks after the radiation, indicating full dysfunction of the bone marrow caused by the radiation. The body weight of BMT-mice in 4 experimental groups was significantly lower than the un-irradiated normal control mice ( Figure 1 , dash line), indicating long-term effect of the lethal X-ray irradiation and subsequent BMT.
The GFP-chimeric mice were treated with the carcinogen NMU and/or H. felis infection and euthanized in the 80 th experimental week as described in the method section. The body weight of mice was transiently decreased one week after NMU treatment but was restored to the level for untreated control mice without NMU treatment after one-week interval (Figure 1) . No animal died in the BMT-control group (N = 10) or the BMT-NMU group (N = 9) within 31 experimental weeks, indicating that the general toxicity of the 240ppm NMU treatment was weak and reversible for these BMT-mice. However, 17 mice in the BMT-NMU and H.felis group (N = 45) and 1 mouse in the BMT-H.felis group (N = 5) died within 31 experimental weeks after H. felis infection. Acute intestine inflammation was observed duing body examination of these mice, indicating the serious intestine toxicity of H. felis infection.
From the 31 st to the 80 th experimental week, gastric intraepithelial neoplasia lesions (GIN) of the glandular stomach were pathologically observed in 9 NMU and H.felis-group mice and 4 NMU-group mice (Figure 2 ). Small intestinal tumors were observed in 2 H.felis-group mice and 2 NMU and H.felis-group mice ( Figure 3 and Figure S3 ). These gastrointestinal tumors were used to investigate whether BMDC cells were the original cells of these tumors.
Characterization of BMDCs in Carcinogen-Induced Gastrointestinal Tumors
To detect the presence of BMDCs in the carcinogen-treated mouse gastrointestinal tumors, GFP direct fluorescence analysis was performed using the frozen tissue samples with opticallyvisible neoplasia lesions (one from the glandular stomach and two from the small intestine that were pathologically diagnosed as GIN or small intestine tumors). Frozen sections were stained with DAPI, and viewed under a confocal laser-scanning fluorescence microscope, then further stained with hematoxylin-eosin (H&E). Unlike the previous report [6] , the GFP(+) BMDC cell clusters were not observed in the glandular epithelium of GINs (Figure 2) , nor in the epithelium of small intestine tumors (Figure 3) . Instead, most GFP(+) cells were located in the tumor stromal tissues.
To further confirm the results of the direct GFP-fluorescence assay, the indirect GFP-IHC staining assay using an antibody against GFP was used to detect GFP(+) cells in 11 paraffinembedded GIN and 2 small intestine tumor samples. As expected, most GFP(+) cells were found in the submucosa and stromal tissues around the dysplastic glands ( Figure 4C and 4D) . No GFP(+) BMDC-derived gland was observed in 11 tested GINs nor in 2 small intestinal tumors (Figure 4 , compare 4C and 4D with 4B).
We considered that some GFP(+) stromal cells were likely to be the tumor -infiltrating hematopoietic cells. To investigate the presence of these cells, tissues were stained for CD45, a commonly used marker for hematopoietic cells except erythrocytes and platelets. The results showed that some GFP(+) stromal cells coexpressed CD45 in the intestinal tumor ( Figure 5 ).
It has been reported that BMDCs can trans-differentiate into myofibroblasts in cancer stroma and promote cancer growth and distant metastasis [7, 13, 14] . To determine whether the GFP(+) stromal cells could be myofibroblasts, the expression status of two myofibroblast-related markers aSMA and SRF in these gastroentestinal tumors were analyzed using cofocal assays. We found that some of the GFP(+) stromal cells indeed co-expressed aSMA and SRF ( Figure 6 ).
Discussion
It has been reported that BMDCs incorporation occurs in gastrointestinal epithelia associated with elevated proliferation and inflammation [6, 15] . In some mouse models, the recruited BMDCs may contribute to new liver epithelia and prostate regrowth [16, 17] . However, in mouse chronic pancreatitis lesion, the frequency of BMDCs in pancreatic ducts is very low [18] . It has also been reported that BMDCs are not the origin of cancer stem cells in ultraviolet induced skin cancers [19] . In addition, one recent clinical study demonstrated that only a small percentage (approximately 1% to 2%) of the colon neoplastic cells was donorderived cells after sex-mismatched bone marrow transplantation [20] . In chronic liver fibrosis, BMDCs is recruited to mouse liver tissues as myofibroblasts [21] . In fact, there has been no following report confirming the ''bone to cancer'' conclusion in the paper published in Science [6] . Although the authors used two independent models to label BMDCs, only indirect assays were performed to track the BMDCs in mouse gastric epithelia. False positive observation cannot completely be excluded in experiments using the indirect assays. To avoid false positive results, we used the direct fluorescence assay to trace GFP(+) BMDCs and confirmed the results with indirect IHC. Unexpectedly, we did not observe any GFP(+) glands or GFP(+) epithelial cell clusters in glands in the carcinogen-induced mouse gastrointestinal tumors.
Bone marrow derived-myofibroblasts in cancer stroma may promote mouse gastric cancer growth or lung cancer metastasis [7, 13, 14] . It has also been suggested that BMDCs contributing to the activated pancreatic stellate cell population in chronic pancreatitis and pancreatic cancer have different phenotypes, and may play important roles in these diseases [22] . aSMA is actively expressed in myofibroblasts and used as aregular marker of myofibroblasts [7] . SRF, another protein actively expressed in stromal myofibroblast, is a master regulator of myogenesis and plays a critical role in myofibroblast differentiation [23] [24] [25] . In the present study, we found that part of GFP(+) stromal cells were also aSMA(+) or SRF(+) myofibroblasts, and some of them were CD45(+) hematopoietic cells in mouse H. felis/NMU-induced gastrointestinal tumors. This is consistent with the previous report that BMC cells that migrated to H. felis-induced gastric tumors can trans-differentiate to myofibroblasts [7] .
Small intestine cancer is a rare cancer in human and its cause is unknown. Interestingly, in the present study, four small intestine cancers were induced by H. felis infection in mice with the bonemarrow transplantation. Frequent mouse death and acute intestine inflammation were observed in the BMT-mice (with or without NMU treatment) after H. felis infection. The reason may be that these BMT-mice become susceptive to the toxicity and carcinogenicity of H. felis infection after the lethal X-irradiation. We found that p16 methylation was very common in somatic cells in different organs including the stomach and small intestine in these irradiated mice (Yang C, et al. unpublished data). It is worth to evaluate the specific toxicity of H. pylori infection among patients with frequent radiotherapy.
In conclusion, the present study suggests that ''bone to cancer'' trans-differentiation may not be the true source of gastrointestinal tumors, or at least not a general phenomenon. Instead, BMDCs might be involved in cancer development through cancer-stromal cell interaction. 
